BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang XP, Li XH, Zhang L, Lin JH, Huang H, Kang T, Mao MJ, Chen H, Zheng X. High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma. BMC Cancer 2016;16:516. [PMID: 27444612 DOI: 10.1186/s12885-016-2502-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cochran BJ, Ong KL, Manandhar B, Rye KA. APOA1: a Protein with Multiple Therapeutic Functions. Curr Atheroscler Rep 2021;23:11. [PMID: 33591433 DOI: 10.1007/s11883-021-00906-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tian D, Jiang KY, Huang H, Jian SH, Zheng YB, Guo XG, Li HY, Zhang JQ, Guo KX, Wen HY. Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study. Ann Transl Med. 2020;8:292. [PMID: 32355736 DOI: 10.21037/atm.2020.02.185] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Mao M, Wang X, Sheng H, Liu Y, Zhang L, Dai S, Chi PD. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients. BMC Cancer 2018;18:1178. [PMID: 30486825 DOI: 10.1186/s12885-018-5028-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 Georgila K, Vyrla D, Drakos E. Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer. Cancers (Basel). 2019;11:1097. [PMID: 31374929 DOI: 10.3390/cancers11081097] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
5 Li P, Wu Y, Zhang Z, Lin D, Wang D, Huang X, Zhang Y. Proteomics analysis identified serum biomarkers for occupational benzene exposure and chronic benzene poisoning. Medicine (Baltimore) 2019;98:e16117. [PMID: 31232959 DOI: 10.1097/MD.0000000000016117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Hao B, Bi B, Sang C, Yu M, Di D, Luo G, Zhang X. Systematic Review and Meta-Analysis of the Prognostic Value of Serum High-Density Lipoprotein Cholesterol Levels for Solid Tumors. Nutrition and Cancer 2019;71:547-56. [DOI: 10.1080/01635581.2019.1577983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Feng JF, Zhao JM, Yang X, Wang L. The Prognostic Impact of Preoperative Serum Apolipoprotein A-I in Patients with Esophageal Basaloid Squamous Cell Carcinoma. Cancer Manag Res 2021;13:7373-85. [PMID: 34588815 DOI: 10.2147/CMAR.S328138] [Reference Citation Analysis]
8 Liao Y, Xing S, Xu B, Liu W, Zhang G. Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma. Oncotarget 2017;8:30050-62. [PMID: 28415791 DOI: 10.18632/oncotarget.16274] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
9 Chang H, Wei JW, Chen K, Zhang S, Han F, Lu LX, Xiao WW, Gao YH. Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy. J Cancer. 2018;9:702-710. [PMID: 29556328 DOI: 10.7150/jca.22836] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
10 Zhang F, Xie Y, Ma X, Gu L, Li H, Li X, Guo G, Zhang X. Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma. Urol Oncol 2019;37:184.e9-184.e17. [PMID: 30509867 DOI: 10.1016/j.urolonc.2018.11.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Shi H, Huang H, Pu J, Shi D, Ning Y, Dong Y, Han Y, Zarogoulidis P, Bai C. Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer. Onco Targets Ther 2018;11:6995-7003. [PMID: 30410356 DOI: 10.2147/OTT.S170227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
12 Huang H, Wang XP, Li XH, Chen H, Zheng X, Lin JH, Kang T, Zhang L, Chen PS. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma. BMC Cancer 2017;17:544. [PMID: 28806937 DOI: 10.1186/s12885-017-3523-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
13 Guo SP, Chen C, Zeng ZF, Wang QX, Jiang W, Gao YH, Chang H. Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy. Cancer Manag Res 2021;13:2623-31. [PMID: 33776480 DOI: 10.2147/CMAR.S302677] [Reference Citation Analysis]
14 Shang Z, Wang J, Wang X, Yan H, Cui B, Jia C, Wang Q, Cui X, Li J, Ou T. Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients. Cancer Manag Res 2018;10:1177-90. [PMID: 29795989 DOI: 10.2147/CMAR.S165213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
15 Zhang Y, Yang X. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis. Dis Markers 2018;2018:1034037. [PMID: 30510601 DOI: 10.1155/2018/1034037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
16 Deng H, Zhou T, Mo X, Liu C, Yin Y. Low-density lipoprotein promotes lymphatic metastasis of esophageal squamous cell carcinoma and is an adverse prognostic factor. Oncol Lett 2019;17:1053-61. [PMID: 30655865 DOI: 10.3892/ol.2018.9683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]